185 related articles for article (PubMed ID: 12639720)
1. Association of phosphorylation site of tau protein with neuronal apoptosis in Alzheimer's disease.
Kobayashi K; Nakano H; Hayashi M; Shimazaki M; Fukutani Y; Sasaki K; Sugimori K; Koshino Y
J Neurol Sci; 2003 Apr; 208(1-2):17-24. PubMed ID: 12639720
[TBL] [Abstract][Full Text] [Related]
2. Regional analysis of differently phosphorylated tau proteins in brains from patients with Alzheimer's disease.
Nakano H; Kobayashi K; Sugimori K; Shimazaki M; Miyazu K; Hayashi M; Furuta H
Dement Geriatr Cogn Disord; 2004; 17(3):122-31. PubMed ID: 14739532
[TBL] [Abstract][Full Text] [Related]
3. 14-3-3 protein beta isoform is associated with 3-repeat tau neurofibrillary tangles in Alzheimer's disease.
Sugimori K; Kobayashi K; Kitamura T; Sudo S; Koshino Y
Psychiatry Clin Neurosci; 2007 Apr; 61(2):159-67. PubMed ID: 17362433
[TBL] [Abstract][Full Text] [Related]
4. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease.
Augustinack JC; Schneider A; Mandelkow EM; Hyman BT
Acta Neuropathol; 2002 Jan; 103(1):26-35. PubMed ID: 11837744
[TBL] [Abstract][Full Text] [Related]
5. Correlation between astrocyte apoptosis and Alzheimer changes in gray matter lesions in Alzheimer's disease.
Kobayashi K; Hayashi M; Nakano H; Shimazaki M; Sugimori K; Koshino Y
J Alzheimers Dis; 2004 Dec; 6(6):623-32; discussion 673-81. PubMed ID: 15665402
[TBL] [Abstract][Full Text] [Related]
6. Transglutaminase bonds in neurofibrillary tangles and paired helical filament tau early in Alzheimer's disease.
Singer SM; Zainelli GM; Norlund MA; Lee JM; Muma NA
Neurochem Int; 2002 Jan; 40(1):17-30. PubMed ID: 11738469
[TBL] [Abstract][Full Text] [Related]
7. Caspase-9 activation and caspase cleavage of tau in the Alzheimer's disease brain.
Rohn TT; Rissman RA; Davis MC; Kim YE; Cotman CW; Head E
Neurobiol Dis; 2002 Nov; 11(2):341-54. PubMed ID: 12505426
[TBL] [Abstract][Full Text] [Related]
8. Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain.
Vincent I; Jicha G; Rosado M; Dickson DW
J Neurosci; 1997 May; 17(10):3588-98. PubMed ID: 9133382
[TBL] [Abstract][Full Text] [Related]
9. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
10. Induction of Bcl-2 and Bax was related to hyperphosphorylation of tau and neuronal death induced by okadaic acid in rat brain.
Chen LQ; Wei JS; Lei ZN; Zhang LM; Liu Y; Sun FY
Anat Rec A Discov Mol Cell Evol Biol; 2005 Dec; 287(2):1236-45. PubMed ID: 16265626
[TBL] [Abstract][Full Text] [Related]
11. Progressive neuronal DNA damage associated with neurofibrillary tangle formation in Alzheimer disease.
Sheng JG; Mrak RE; Griffin WS
J Neuropathol Exp Neurol; 1998 Apr; 57(4):323-8. PubMed ID: 9600224
[TBL] [Abstract][Full Text] [Related]
12. Earliest stages of tau conformational changes are related to the appearance of a sequence of specific phospho-dependent tau epitopes in Alzheimer's disease.
Luna-Muñoz J; Chávez-Macías L; García-Sierra F; Mena R
J Alzheimers Dis; 2007 Dec; 12(4):365-75. PubMed ID: 18198423
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E immunoreactivity within neurofibrillary tangles: relationship to Tau and PHF in Alzheimer's disease.
Benzing WC; Mufson EJ
Exp Neurol; 1995 Apr; 132(2):162-71. PubMed ID: 7540552
[TBL] [Abstract][Full Text] [Related]
14. The pathological process underlying Alzheimer's disease in individuals under thirty.
Braak H; Del Tredici K
Acta Neuropathol; 2011 Feb; 121(2):171-81. PubMed ID: 21170538
[TBL] [Abstract][Full Text] [Related]
15. Immunocytochemistry of neurofibrillary tangles with antibodies to subregions of tau protein: identification of hidden and cleaved tau epitopes and a new phosphorylation site.
Dickson DW; Ksiezak-Reding H; Liu WK; Davies P; Crowe A; Yen SH
Acta Neuropathol; 1992; 84(6):596-605. PubMed ID: 1281953
[TBL] [Abstract][Full Text] [Related]
16. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
[TBL] [Abstract][Full Text] [Related]
17. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
van de Nes JA; Nafe R; Schlote W
Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
[TBL] [Abstract][Full Text] [Related]
18. [Significance of tau in the development of Alzheimer's disease].
Takashima A
Brain Nerve; 2010 Jul; 62(7):701-8. PubMed ID: 20675874
[TBL] [Abstract][Full Text] [Related]
19. Relationship between DNA fragmentation, morphological changes and neuronal loss in Alzheimer's disease and dementia with Lewy bodies.
Broe M; Shepherd CE; Milward EA; Halliday GM
Acta Neuropathol; 2001 Jun; 101(6):616-24. PubMed ID: 11515791
[TBL] [Abstract][Full Text] [Related]
20. Divergent phosphorylation pattern of tau in P301L tau transgenic mice.
Deters N; Ittner LM; Götz J
Eur J Neurosci; 2008 Jul; 28(1):137-47. PubMed ID: 18662339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
